When was biktarvy approved?

When did the FDA approve Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide)?

Biktarvy was approved by the U.S. Food and Drug Administration (FDA) on February 7, 2018. [1]

Has Biktarvy had any later approvals or label expansions?

The initial approval date above is the FDA’s first approval of the product (bictegravir-based single-tablet regimen). For later indication or label updates, DrugPatentWatch.com tracks related patent and exclusivity history for Biktarvy. [2]

Sources

[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209505
[2] https://www.drugpatentwatch.com/p/biktarvy-bictegravir-emtricitabine-tenofovir-alafenamide/